Back to Resona Asset Management Co., Ltd. Resona Asset Management Co., Ltd.

ALNYALNY

Showing 8 of 10 quarters

Position history for Resona Asset Management Co., Ltd.Resona Asset Management Co., Ltd.'s holdings in Alnylam Pharmaceuticals, Inc.

Yes. Resona Asset Management holds 40,053 shares of ALNY (Alnylam Pharmaceuticals), worth $12M, as of its Q2 2026 13F filing. It increased the position by 221 shares (+0.6%) from Q1 2026. Resona Asset Management has held ALNY in every 13F on record since Q1 2024, 10 quarterly filings. ALNY is 0.1% of Resona Asset Management's reported 13F portfolio.

Current Value

$12M

Current Shares

40,053

Total Value Change

+$1.7M

Total Shares Change

+2,476

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
40,053
+0.6%
$12M0.1%$301.03
28
2026-Q1
Increased
39,832
+1.5%
$13.1M0.1%$330.87
28
2025-Q4
Decreased
39,247
-5.4%
$15.6M0.1%$397.65
0
2025-Q3
Decreased
41,497
-5.0%
$18.9M0.1%$456.00
0
2025-Q2
Increased
43,700
+12.3%
$14.2M0.1%$326.09
31
2025-Q1
Increased
38,920
+6.2%
$10.5M0.1%$270.02
30
2024-Q4
Decreased
36,656
-2.5%
$8.6M0.1%$235.31
0
2024-Q3
Decreased
37,577
-13.6%
$10.3M0.1%$275.03
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used